Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of the 5'-truncated
Rgr
oncogene, a previously shown specific guanine exchange factor for Ral in vitro, in stimulating proliferation, cell transformation and gene expression were investigated. We have established TetRgr cell lines in which expression of
Rgr
can be inhibited by the presence of tetracycline in the medium. Using this system, we show that
Rgr
overexpressing cells are morphologically transformed and grow in a disorganized manner. At the transcriptional level,
Rgr
enhances the activity of the serum response element and c-Jun.
Rgr
induces phosphorylation of ERKs, p38 and JNK kinases, and increases the levels of the GTP-bound forms of Ral and Ras. Ras activation could account for the broad spectra of effects displayed by
Rgr
. The important role of these pathways is confirmed by experiments in which the transcriptional activation events can be blocked by dominant negative versions of Ras, Ral and Rho. Among all the
Rgr
-induced pathways, the Ras-Raf-
MEK
-ERK cascade is essential for the transforming properties of
Rgr
. Additional analysis has shown that the activation of this pathway by
Rgr
is not due to a feed back mechanism mediated by the Grb2 adaptor protein. Oncogene (2000).
...
PMID:The Rgr oncogene (homologous to RalGDS) induces transformation and gene expression by activating Ras, Ral and Rho mediated pathways. 1085 Oct 75